Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.8827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Joshua Burshtein und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms, Hedgehog Proteins, Pyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Burshtein, J., Shah, M., Zakria, D., Dinehart, S., Lewin, J., Monks, G., Mortazie, M., Trotter, S., Schlesinger, T., Lebwohl, M., & Rigel, D. (2025). Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8827
Vancouver
Burshtein J, Shah M, Zakria D, Dinehart S, Lewin J, Monks G, et al. Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8827
BibTeX
@article{Burshtein2025,
author = {Burshtein, Joshua and Shah, Milaan and Zakria, Danny and Dinehart, Scott and Lewin, Jesse and Monks, George and Mortazie, Michael and Trotter, Shannon and Schlesinger, Todd and Lebwohl, Mark and Rigel, Darrell},
title = {Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.8827}
}
EUVIMED